Risk prediction is improved by adding markers of subclinical organ damage to SCORE

被引:213
|
作者
Sehestedt, Thomas [1 ,2 ]
Jeppesen, Jorgen [1 ]
Hansen, Tine W. [2 ,3 ]
Wachtell, Kristian [4 ]
Ibsens, Hans [5 ]
Torp-Petersen, Christian [6 ]
Hildebrandt, Per [1 ]
Olsen, Michael H. [1 ]
机构
[1] Glostrup Univ Hosp, Dept Internal Med, Cardiovasc Res Unit, DK-2600 Glostrup, Denmark
[2] Res Ctr Prevent & Hlth, Copenhagen, Denmark
[3] Hvidovre Univ Hosp, Dept Clin Physiol & Nucl Med, DK-2650 Hvidovre, Denmark
[4] Rigshosp, Dept Cardiol, Copenhagen, Denmark
[5] Holbaek Cent Hosp, Dept Internal Med, Holbaek, Denmark
[6] Gentofte Univ Hosp, Dept Cardiol, Gentofte, Denmark
关键词
Risk stratification; SCORE; Atherosclerotic plaques; Albuminuria; Pulse wave velocity; Left ventricular hypertrophy; CORONARY-HEART-DISEASE; BRAIN NATRIURETIC PEPTIDE; LEFT-VENTRICULAR MASS; C-REACTIVE PROTEIN; CARDIOVASCULAR RISK; MYOCARDIAL-INFARCTION; PRIMARY HYPERTENSION; AORTIC STIFFNESS; ROC CURVE; MICROALBUMINURIA;
D O I
10.1093/eurheartj/ehp546
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims It is unclear whether subclinical vascular damage adds significantly to Systemic Coronary Risk Evaluation (SCORE) risk stratification in healthy subjects. Methods and results In a population-based sample of 1968 subjects without cardiovascular disease or diabetes not receiving any cardiovascular, anti-diabetic, or lipid-lowering treatment, aged 41, 51, 61, or 71 years, we measured traditional cardiovascular risk factors, left ventricular (LV) mass index, atherosclerotic plaques in the carotid arteries, carotid/femoral pulse wave velocity (PWV), and urine albumin/creatinine ratio (UACR) and followed them for a median of 12.8 years. Eighty-one subjects died because of cardiovascular causes. Risk of cardiovascular death was independently of SCORE associated with LV hypertrophy [hazard ratio (HR) 2.2 (95% Cl 1.2-4.0)], plaques [HR 2.5 (1.6-4.0)], UACR >= 90th percentile [HR 3.3 (1.8-5.9)], PWV > 12 m/s [HR 1.9 (1.1-3.3) for SCORE >= 5% and 7.3 (3.2-16.1) for SCORE < 5%]. Restricting primary prevention to subjects with SCORE >= 5% as well as subclinical organ damage, increased specificity of risk prediction from 75 to 81% (P < 0.002), but reduced sensitivity from 72 to 65% (P = 0.4). Broaden primary prevention from subjects with SCORE >= 5% to include subjects with 1% <= SCORE < 5% together with subclinical organ damage increased sensitivity from 72 to 89% (P = 0.006), but reduced specificity from 75 to 57% (P < 0.002) and positive predictive value from 11 to 8% (P = 0.07). Conclusion Subclinical organ damage predicted cardiovascular death independently of SCORE and the combination may improve risk prediction.
引用
收藏
页码:883 / 891
页数:9
相关论文
共 50 条
  • [41] Subclinical target organ damage in normotensive and prehypertensive patients
    Yi, Hong
    Zhang, Wei-Zhen
    Zhang, Hua
    Chen, Yuan-Hong
    Zhou, Ming-Cheng
    MINERVA CARDIOANGIOLOGICA, 2017, 65 (01): : 16 - 23
  • [42] Cardiovascular risk factors and subclinical organ damage in children after hematopoietic stem cell transplantation
    Borchert-Moerlins, Bianca
    Dadgar, Nima Memaran
    Sauer, Martin
    Maecker-Kolhoff, Britta
    Sykora, Karl-Walter
    Blote, Ricarda
    Bauer, Elena
    Schmidt, Bernahrd M. W.
    Melk, Anette
    Beier, Rita
    BONE MARROW TRANSPLANTATION, 2018, 53 : 489 - 490
  • [43] Subclinical organ damage in perimenopausal women with essential hypertension
    Olszanecka, Agnieszka
    Posnik-Urbanska, Aneta
    Kawecka-Jaszcz, Kalina
    Czarnecka, Danuta
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2010, 120 (10): : 390 - 398
  • [44] CARDIOVASCULAR RISK STRATIFICATION AND CORRELATION BETWEEN SUBCLINICAL ORGAN DAMAGE IN BOTH GENDERS OF HYPERTENSIVE PATIENTS
    Posadzy-Malaczynska, Anna
    Woznicka-Leskiewicz, Lucyna
    JOURNAL OF HYPERTENSION, 2023, 41 : E136 - E137
  • [45] Abdominal obesity and low-grade systemic inflammation as markers of subclinical organ damage in type 2 diabetes
    Dahlen, E. M.
    Tengblad, A.
    Lanne, T.
    Clinchy, B.
    Ernerudh, J.
    Nystrom, F. H.
    Ostgren, C. J.
    DIABETES & METABOLISM, 2014, 40 (01) : 76 - 81
  • [46] Cardiovascular risk assessment beyond Systemic Coronary Risk Estimation: a role for organ damage markers
    Volpe, Massimo
    Battistoni, Allegra
    Tocci, Giuliano
    Rosei, Enrico Agabiti
    Catapano, Alberico L.
    Coppo, Rosanna
    del Prato, Stefano
    Gentile, Sandro
    Mannarino, Elmo
    Novo, Salvatore
    Prisco, Domenico
    Mancia, Giuseppe
    JOURNAL OF HYPERTENSION, 2012, 30 (06) : 1056 - 1064
  • [47] Shooting beyond score: targeting organ disease to improve risk prediction in hypertension
    Volpe, Massimo
    Tocci, Giuliano
    Battistoni, Allegra
    JOURNAL OF HYPERTENSION, 2012, 30 (10) : 1909 - 1910
  • [48] IMPROVED PREDICTION OF PRIMARY OSTEOPOROSIS LEVERAGING A POLYGENIC RISK SCORE IN WOMEN
    Yalaev, B. I.
    Tyurin, A. V.
    Khusainova, R. I.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (SUPPL 1) : S226 - S227
  • [49] Improved Interpretability Without Performance Reduction in a Sepsis Prediction Risk Score
    Kotter, Adam
    Abdelrahman, Samir
    Wan, Yi-Ki Jacob
    Madaras-Kelly, Karl
    Morgan, Keaton L.
    Kan, Chin Fung Kelvin
    Del Fiol, Guilherme
    DIAGNOSTICS, 2025, 15 (03)
  • [50] Improved prediction of fracture risk leveraging a genome-wide polygenic risk score
    Lu, Tianyuan
    Forgetta, Vincenzo
    Keller-Baruch, Julyan
    Nethander, Maria
    Bennett, Derrick
    Forest, Marie
    Bhatnagar, Sahir
    Walters, Robin
    Lin, Kuang
    Chen, Zhengming
    Li, Liming
    Karlsson, Magnus
    Mellstrom, Dan
    Orwoll, Eric
    McCloskey, Eugene
    Kanis, John
    Leslie, William
    Clarke, Robert
    Ohlsson, Claes
    Greenwood, Celia
    Richards, Brent
    JOURNAL OF BONE AND MINERAL RESEARCH, 2020, 35 : 134 - 134